Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

University Lab Licenses Printed Kidney Tissue Process

Kidney organoid with capillary

A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure. . . . → Read More: University Lab Licenses Printed Kidney Tissue Process

Synthetic SARS-CoV-2 Particle Designed for Drug R&D

DNA chip graphic

Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers. . . . → Read More: Synthetic SARS-CoV-2 Particle Designed for Drug R&D

Infographic – Climate Investments Skyrocket in 2021

Chart: Climate venture investments

Venture investments in 2021 more than quadrupled from 2020 to nearly $9.3 billion, in companies developing technologies addressing the climate crisis. . . . → Read More: Infographic – Climate Investments Skyrocket in 2021

Alzheimer’s Vaccine Shown to Produce Immune Response

Brain activity graphic

In tests with lab animals, an experimental vaccine is shown to generate antibodies responding to toxic brain proteins associated with Alzheimer’s disease. . . . → Read More: Alzheimer’s Vaccine Shown to Produce Immune Response

Start-Ups Partner on Quantum Computing and Longevity

Quantum physics

Two companies formed in the last two years are applying quantum computing and artificial intelligence to discover new treatments for improving human longevity. . . . → Read More: Start-Ups Partner on Quantum Computing and Longevity

Health Breakthrough Research Group Doubles Funding

Growing money

A not-for-profit organization that sponsors accelerated and high-impact health research worldwide says it gained a new $335 million in funding. . . . → Read More: Health Breakthrough Research Group Doubles Funding

Precision Cancer Genomics Company Adds $23M in Early Funds

DNA analysis graphic

Biofidelity says its process simplifies detection of genetic indicators in tumors enabling more precise therapies for cancer patients. . . . → Read More: Precision Cancer Genomics Company Adds $23M in Early Funds